Gwada-negative: The Rarest Blood Group on Earth

French scientists have discovered the world's rarest blood group, Gwada-negative, found in a woman from Guadeloupe. This groundbreaking finding highlights the complexity of human blood systems and the potential for future personalized transfusion solutions.
In a groundbreaking discovery, French scientists have identified the world's rarest blood group, known as "Gwada-negative." The only confirmed carrier is a woman from Guadeloupe, whose blood is so unique that no compatible donor has been found despite testing numerous potential samples. This discovery underscores the complexity of human blood systems beyond the familiar A, B, AB, and O types, which include the Rh factor. Blood groups are defined by specific proteins and sugars on the surface of red blood cells, crucial for transfusion compatibility.
The investigation began when the woman’s plasma reacted negatively with all tested donors’ blood samples, including her relatives, indicating an entirely new blood group. To pinpoint the cause, scientists employed advanced genetic analysis techniques, specifically whole exome sequencing, which examines all human genes. They discovered a mutation in the PIGZ gene, which encodes an enzyme essential for adding a sugar molecule to cell membrane components. This mutation prevents the addition of a specific sugar, resulting in a new antigen on red blood cells, leading to classification as Gwada-positive or -negative.
Further genetic experiments confirmed that this mutation creates a unique blood group. The woman remains the only known Gwada-negative individual, raising concerns about transfusion safety and her medical management. She has experienced mild intellectual disability and has lost two babies at birth, conditions potentially linked to her genetic mutation.
The PIGZ enzyme operates at the final stage of GPI (glycosylphosphatidylinositol) molecule synthesis, vital for cell membrane functions. Deficiencies in similar enzymes are associated with neurological issues and developmental delays. Given the extreme rarity of Gwada-negative blood, providing compatible transfusions in emergencies presents significant challenges. The possibility of lab-grown or genetically modified red blood cells offers a future solution, using stem cells to produce matching blood types for such rare cases.
This discovery adds Gwada to the growing roster of recognized blood group systems, now totaling 48. Named after Guadeloupe—"Gwada"—the blood group highlights the deep genetic diversity present in humans and the ongoing evolution of transfusion medicine. As genetic sequencing technology advances, scientists foresee more rare blood types being identified, which can improve personalized medical treatments and deepen our understanding of human variation.
Source: https://medicalxpress.com/news/2025-07-gwada-negative-rarest-blood-group.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Enhanced Skin-to-Skin Contact with Newborns Driving Positive Outcomes Post-Training
Targeted training for healthcare professionals and parents significantly increases skin-to-skin contact with newborns, supporting better bonding and health outcomes in the first days of life.
Exercise During Chemotherapy Enhances Immune Response Against Cancer
New research shows that exercise during chemotherapy can boost immune cells within tumors, potentially improving cancer treatment outcomes. A pioneering study highlights the benefits of physical activity in enhancing tumor immunity in esophageal cancer patients.
Q&A: How Research on Mpox is Preparing Scientists for Future Pandemics
Research on mpox has led to crucial insights into the virus, treatment efficacy, and the role of clinical trials during outbreaks, helping scientists better prepare for future pandemics.
Experts Highlight the Importance of Reducing Screen Time and Focusing on Infant Brain Development for Better Long-Term Health and Cognitive Outcomes
Research highlights the importance of limiting screen time and promoting face-to-face interaction in infancy to support healthy brain development and improve long-term health outcomes.